Usc Care Medical Group Inc

“Certain individuals listed in part vii are officers and directors of the university of southern california, a related organization. All individuals listed with related organization compensation are compensated by the university.”

“The sole corporate member of the organization is the usc health system, a california tax-exempt organization. The corporate member has the authority to approve directors elected by the board and remove directors and the authority to approve changes to the bylaws. Actions requiring approval of the corporate member include any changes to the composition of the board of directors, bylaw changes, certain property transactions, budget approval, and approval of certain contracts and purchase agreements.”

“Usc care medical group's form 990 is reviewed at several levels. The medical group engages an external public accounting firm to assist in the preparation and review of its form 990 and to sign as paid preparer. Among those who conduct the review of the final form 990 at the medical group include management, and the audit, compliance, and risk committee of the usc health system. The review of form 990 is conducted prior to it being filed and a final copy of the form 990 is provided to each member of the board of directors of the usc health system before it is filed.”

“As a related organization of the usc health system, the organization follows the health system's policies including the conflict of interest policy. The conflict of interest policy covers all interested persons employees and their close relations. Interested persons will continue to be subject to the policy for five years after ceasing to be an interested person. An "interested person" means any director, member of any committee appointed by the board (whether or not such person is a director), principal officer, or key employee who has a direct or indirect financial interest in a contemplated transaction or arrangement. In connection with any actual or potential conflict of interest, an interested person must fully disclose the existence of and all material facts related to the financial interest that gives rise to the actual or potential conflict of interest. Such disclosure shall be made to the chair of the board, the chair of the executive committee, or the chair of such other committee of the board as is authorized to review such transaction or arrangement referred to as an "appropriate committee". If a director, committee member, principal officer, or key employee becomes aware of any actual or potential conflict of interest related to another director, committee member, principal officer, or key employee, such person shall promptly bring it to the attention of the chair of the board, the chair of the executive committee, or the chair of an appropriate committee. After disclosure of the financial interest and all material facts, and after any discussion with the interested person, the interested person shall be excused from the meeting of the board or appropriate committee during the discussion of the financial interest and the vote on whether a conflict of interest exists, which shall be determined by a majority of a disinterested quorum. The remaining board or committee members (or the sole member if there are no disinterested directors) shall decide if a conflict of interest exists. If the remaining board or committee members determine that the financial interest of an interested person does not constitute an actual or potential conflict of interest, the review process is complete. If an actual or potential conflict of interest has been found, the board or committee shall proceed as follows: the interested person shall be excused from the meeting during the discussion of, and the vote on, the transaction or arrangement, provided that the interested person may with the permission or at the request of the presiding officer address the meeting with respect to the transaction or arrangement before leaving the meeting. The body that considers the proposed transaction or arrangement shall be composed entirely of individuals without a conflict of interest with respect to the proposed transaction or arrangement. The board or appropriate committee may appoint a disinterested person or committee of disinterested persons to investigate alternatives to the proposed transaction or arrangement before voting on such transaction or arrangement. Further, legal counsel may be consulted if desired by the board or committee prior to considering the transaction or arrangement. The board or an appropriate committee (except as provided below), after the exercise of reasonable due diligence, may authorize or approve a transaction or arrangement by vote of a majority of the disinterested directors on the board or such committee after making the determinations set forth. If a director has a material financial interest in a transaction or arrangement, then the transaction or arrangement may only be approved by action taken by the full board, or by an appropriate committee. To authorize or approve a transaction or arrangement, the board or appropriate committee must determine the following: that the board (or appropriate committee) has knowledge of all material facts concerning the transaction or arrangement and the financial or other interest o”

“Usc care medical group, inc. Follows the university of southern california's written document retention, whistleblower, and joint venture policies which were previously issued by university management and are currently in effect. All policies go to the clinical practices committee for approval.”

“As a related organization of usc health system, the compensation of the organization's ceo, officers and key employees is determined annually by the usc health system board of directors' executive compensation committee using the safe harbor process described in treasury regulation section 53.4958-6. Namely, a committee of the usc health system's board of directors takes the following three steps: (1) it ensures that no member of the committee has a conflict of interest with respect to the compensation arrangement being reviewed, (2) it looks to comparability data and specialized compensation reports (and in some cases opinions) prepared for the organization by independent compensation consultants with respect to similarly qualified individuals in comparable positions at similarly situated organizations, and (3) it maintains a contemporaneous record of its deliberations and decisions. The compensation for the president of usc care medical group is set via the annual review process for faculty (as the president is a faculty physician of the university of southern california) through the office of the vice provost for academic and faculty affairs.”

“The organization's bylaws are made available to the public upon request. The organization files under consolidated financial statements with the university of southern california and also follows the university's policies. The financial statements and conflict of interest policies are made available to the public on the university of southern california's website.”

“The title for david peng, md, mph is president/director until 5/30/24.”

“To promote health by engaging in the practice of medicine for patients of hospitals affiliated with the university of southern california keck school of medicine and elsewhere. To provide medical care to the sick and injured who may come to this corporation for diagnosis, treatment and care without regard to race, color, creed, sex, age or ability to pay for services and particularly to provide such medical care for persons who seek such care at hospitals and other health care facilities affiliated with the university.”

“OTHER CHANGES IN NET ASSETS TRANSFER TO USC KECK SCHOOL OF MEDICINE - MISSION SUPPORT $-7,944,344 Working capital transfer $ 7,516 OTHER $ 9 _____________ OTHER CHANGES IN NET ASSETS OR FUND BALANCES $-7,936,819”